Applying Motivation-Phase Interventions to Treat Tobacco Use Among People with Opioid Use Disorder
Our speaker is Elias Klemperer, PhD, Assistant Professor of Psychiatry and Psychological Science at the University of Vermont. This presentation is on the importance of tobacco treatment for people with opioid use disorder and discusses research on providing treatment for smokers who are not motivated or not ready to quit. It also explores barriers to quitting tobacco among those who live in rural communities.
1. Discuss the importance of tobacco treatment for people with opioid use disorder
2. Explain how lack of motivation or readiness to quit in the near future is a common barrier for tobacco use disorder
3. Consider special barriers to quitting tobacco among those who live in rural communities
4. Identify treatment strategies for tobacco users who are not motivated to quit
Elias Klemperer, PhD
Dr. Klemperer is an Assistant Professor at the University of Vermont in the Departments of Psychiatry and Psychological Science. As an investigator with the Vermont Center on Behavior and Health, Dr. Klemperer’s research primarily develops clinical and regulatory interventions to reduce harm from tobacco use, with a particular focus on nicotine reduction and dual users of cigarettes and e-cigarettes. In addition, Dr. Klemperer has a growing program of research on the treatment of opioid use disorder among people who are incarcerated or recently released from incarceration in rural communities.